CytoDyn Inc.
CYDY
$0.3172
$0.00722.32%
OTC PK
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.85M | 1.51M | 2.29M | 1.60M | 3.06M |
| Depreciation & Amortization | -14.00K | 5.00K | 4.00K | 5.00K | -25.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.07M | 4.00M | 3.71M | 2.55M | 6.63M |
| Operating Income | -5.07M | -4.00M | -3.71M | -2.55M | -6.63M |
| Income Before Tax | -5.96M | -4.76M | -4.77M | 19.23M | -16.79M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.96M | -4.76M | -4.77M | 19.23M | -16.79M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.96M | -4.76M | -4.77M | 19.23M | -16.79M |
| EBIT | -5.07M | -4.00M | -3.71M | -2.55M | -6.63M |
| EBITDA | -5.06M | -4.00M | -3.70M | -2.54M | -6.63M |
| EPS Basic | -0.01 | 0.00 | 0.00 | 0.02 | -0.02 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| EPS Diluted | -0.01 | 0.00 | 0.00 | 0.02 | -0.02 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Average Basic Shares Outstanding | 1.24B | 1.23B | 1.22B | 1.14B | 1.01B |
| Average Diluted Shares Outstanding | 1.24B | 1.23B | 1.22B | 1.20B | 1.01B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |